AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 1 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $737 | -99.9% | 49,299 | -67.4% | 0.00% | -100.0% |
| Q3 2022 | $1,245,000 | -70.5% | 151,317 | -76.5% | 0.00% | -66.7% |
| Q2 2022 | $4,220,000 | -36.6% | 643,250 | -46.0% | 0.00% | 0.0% |
| Q1 2022 | $6,652,000 | +57.6% | 1,190,104 | +32.2% | 0.00% | +50.0% |
| Q4 2021 | $4,221,000 | -2.6% | 899,968 | +28.3% | 0.00% | -33.3% |
| Q3 2021 | $4,334,000 | +19.9% | 701,275 | +27.8% | 0.00% | +50.0% |
| Q2 2021 | $3,616,000 | +438.9% | 548,685 | +499.0% | 0.00% | – |
| Q1 2021 | $671,000 | +37.5% | 91,601 | +8.2% | 0.00% | – |
| Q4 2020 | $488,000 | -20.1% | 84,627 | -28.7% | 0.00% | -100.0% |
| Q2 2020 | $611,000 | – | 118,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $22,809,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 1,151,175 | $6,642,000 | 0.47% |
| X-Square Capital, LLC | 75,952 | $438,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 68,092 | $393,000 | 0.08% |
| WealthTrust Axiom LLC | 22,347 | $128,000 | 0.05% |
| Opaleye Management Inc. | 58,800 | $339,000 | 0.04% |
| Trexquant Investment LP | 64,838 | $374,000 | 0.04% |
| PDT Partners, LLC | 60,117 | $347,000 | 0.02% |
| PERSONAL CFO SOLUTIONS, LLC | 13,000 | $75,000 | 0.02% |
| CVI Holdings, LLC | 13,171 | $76,000 | 0.01% |